title: Cytomegalovirus retinitis in HIV-negative patients: a practical management approach.
authors.affiliation: Ocular Oncology and Autoimmune Center, The Goldschleger Eye Institute; Sheba Medical Center, the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: vivida65@gmail.com.
authors.forename: Vicktoria
authors.initials: V
authors.lastname: Vishnevskia-Dai
authors.affiliation: Ocular Oncology and Autoimmune Center, The Goldschleger Eye Institute; Sheba Medical Center, the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Yinon
authors.initials: Y
authors.lastname: Shapira
authors.affiliation: Infectious Diseases Unit; Sheba Medical Center, the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Galia
authors.initials: G
authors.lastname: Rahav
authors.affiliation: The Bone Marrow Transplantation Department; Sheba Medical Center, the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Avichai
authors.initials: A
authors.lastname: Shimoni
authors.affiliation: Pediatric Department B, Edmond and Lily Safra Children's Hospital, and Cancer Research Center, Pediatric Immunology Service, Jeffrey Modell Foundation (JMF) Center; Sheba Medical Center, the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Raz
authors.initials: R
authors.lastname: Somech
authors.affiliation: Ocular Oncology and Autoimmune Center, The Goldschleger Eye Institute; Sheba Medical Center, the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Joseph
authors.initials: J
authors.lastname: Moisseiev
mesh_terms: D000328:Adult; D000368:Aged; D000956:Antigens, Viral / Q000235:genetics; D000998:Antiviral Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D003587:Cytomegalovirus / Q000235:genetics / Q000302:isolation & purification; D017726:Cytomegalovirus Retinitis / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005260:Female; D017245:Foscarnet / Q000627:therapeutic use*; D015774:Ganciclovir / Q000627:therapeutic use*; D018023:HIV Seronegativity; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics; D007223:Infant; D007275:Injections, Intravenous; D058449:Intravitreal Injections; D008297:Male; D016133:Polymerase Chain Reaction; D012189:Retrospective Studies; D019562:Viral Load; D014792:Visual Acuity / Q000502:physiology
chemical_list: D000956:Antigens, Viral; D000998:Antiviral Agents; D017874:Immediate-Early Proteins; C044582:immediate-early proteins, cytomegalovirus; D017245:Foscarnet; D015774:Ganciclovir